In hepatocellular carcinoma (HCC), α-fetoprotein (AFP) levels inform therapeutic intensity and surveillance intervals, while liver-fibrosis staging determines surgical candidacy and transplant eligibility [29, 30]. This evidence concerns the gene AFP and hepatocellular carcinoma.